Those on the 3-mg dose lost an average of 4.5% of their bodyweight, rising to 5.8% with the 12-mg dose group, and 7.6% for the 36-mg dose compared to a 1.7% reduction for the placebo group
The metabolism and clearance of both components may be affected by significant liver disease, and patients with severe hepatic impairment should be monitored closely if treatment is deemed necessary
[DOI] [PubMed] [Google Scholar] 186.Navarathna DH, Roberts DD
Helped me stay on track!!! This app has been so helpful starting my weight loss journey
Regarding the dosage of LC, Musazadeh et al
They are very popular in Sri Lanka due to false marketing," Dr Weerasuriya, former CEO of the national medicines regulatory authority in Sri Lanka, told the ABC